ScandiDos AB (OSTO:SDOS) 6-Month Price Index: 0.92 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SDOS ScandiDos AB OSTO:SDOS
47 GF Score
Price kr0.87
GF Value kr1.12
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is ScandiDos AB 6-Month Price Index?

ScandiDos AB OSTO:SDOS +2.35% 47 6-Month Price Index is 0.92 as of Sep. 16, 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 47/100 and a GF Value™ of kr1.12 (Modestly Undervalued). The stock has 4 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-16), ScandiDos AB's 6-Month Price Index is 0.92.

ScandiDos AB  (OSTO:SDOS) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

ScandiDos AB 6-Month Price Index Related Terms

OSTO:SDOS vs ABT, SYK, MDT: 6-Month Price Index Comparison

For the Medical Devices subindustry, ScandiDos AB's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSTO:SDOS
47GF Score
ScandiDos AB OSTO:SDOS
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ScandiDos AB  (OSTO:SDOS) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.92 mean?
ScandiDos AB (OSTO:SDOS) has a 6-Month Price Index of 0.92 as of Sep. 16, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on ScandiDos AB and its competitors.
Is ScandiDos AB's 6-Month Price Index too high?
ScandiDos AB's current 6-Month Price Index is 0.92. Overall, ScandiDos AB has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's 6-Month Price Index compare to ABT and SYK?
ScandiDos AB's 6-Month Price Index of 0.92 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on ScandiDos AB and its competitors. ScandiDos AB's current 6-Month Price Index is 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.12, compared to a current price of kr0.87 — trading 22.3% below its estimated fair value. The current 6-Month Price Index is 0.92. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current 6-Month Price Index is 0.92 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of kr0.87 is trading 22.3% below its estimated GF Value™ of kr1.12. GuruFocus considers ScandiDos AB to be Modestly Undervalued.

Key valuation signals for OSTO:SDOS:

  • 6-Month Price Index: 0.92
  • GF Value™: kr1.12 vs. price of kr0.87 (22.3% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Address Uppsala Science Park, Uppsala, SWE, SE-751 83
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score

Get the complete analysis for OSTO:SDOS

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.87
Price
kr1.12
GF Value